Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

19.76
-0.5900-2.90%
Post-market: 19.760.00000.00%19:55 EDT
Volume:1.27M
Turnover:25.07M
Market Cap:573.20M
PE:-59.23
High:20.76
Open:20.27
Low:19.14
Close:20.35
Loading ...
Oct 19, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Apr 09, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2021

Major Issues Report

8-K - Current report